Carregant...
The Efficacy and Safety of Low‐ and High‐ Dose Fixed Combinations of Irbesartan/Hydrochlorothiazide in Patients With Uncontrolled Systolic Blood Pressure on Monotherapy: The INCLUSIVE Trial
This multicenter, prospective, open‐label, single‐arm study determined the efficacy and safety of irbesartan/hydrochlorothiazide (HCTZ) fixed combinations in patients (n=1005), aged 18 years and older, with uncontrolled systolic blood pressure (SBP) of 140–159 mm Hg (130–159 mm Hg for type 2 diabete...
Guardat en:
| Publicat a: | J Clin Hypertens (Greenwich) |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Le Jacq Ltd.
2007
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8109614/ https://ncbi.nlm.nih.gov/pubmed/16227760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2004.04720.x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|